We examined the role of the complement system in the pathogenesis of dermatomyositis. Using an antibody against the neoantigens of the terminal C5b-9 membrane attack complex, we performed immunocytochemical studies that localized this complex to the intramuscular microvasculature (arterioles and capillaries) of muscle biopsy specimens from 10 of 12 patients (83 percent) with childhood dermatomyositis and 5 of 19 patients (26 percent) with adult dermatomyositis. Fifty-two control specimens, including 14 from patients with polymyositis and 12 from patients with denervation atrophy (a condition known to be associated with necrotic capillaries), showed no deposition of membrane attack complex in the microvasculature. These findings indicate that the complement system is deposited, bound, and activated to completion within the intramuscular microvasculature of patients with dermatomyositis. In addition to providing further evidence for the presence of vasculopathy in dermatomyositis, these findings suggest a primary role for complement in mediating vessel injury in the disease, particularly in its childhood form.
This article has been cited by other articles:
Dalakas, M. C.
(2008). Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Therapeutic Advances in Neurological Disorders
1: 157-166
[Abstract]
Greenberg, S. A.
(2007). Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology
69: 2008-2019
[Abstract][Full Text]
Helmers, S. B., Dastmalchi, M., Alexanderson, H., Nennesmo, I., Esbjornsson, M., Lindvall, B., Lundberg, I. E
(2007). Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis
66: 1276-1283
[Abstract][Full Text]
Gunawardena, H., Harris, N. D., Carmichael, C., McHugh, N. J.
(2007). Microvascular responses following digital thermal hyperaemia and iontophoresis measured by laser Doppler imaging in idiopathic inflammatory myopathy. Rheumatology (Oxford)
46: 1483-1486
[Abstract][Full Text]
Chung, L., Genovese, M. C., Fiorentino, D. F.
(2007). A Pilot Trial of Rituximab in the Treatment of Patients With Dermatomyositis. Arch Dermatol
143: 763-767
[Abstract][Full Text]
Sakuta, R., Murakami, N., Jin, Y., Nagai, T., Nonaka, I., Nishino, I.
(2005). Diagnostic Significance of Membrane Attack Complex and Vitronectin in Childhood Dermatomyositis. J Child Neurol
20: 597-602
[Abstract]
Kiely, P. D. W., Heron, C. W., Bruckner, F. E.
(2003). Presentation and management of idiopathic inflammatory muscle disease: four case reports and commentary from a series of 78 patients. Rheumatology (Oxford)
42: 575-582
[Full Text]
Greenberg, S. A., Sanoudou, D., Haslett, J. N., Kohane, I. S., Kunkel, L. M., Beggs, A. H., Amato, A. A.
(2002). Molecular profiles of inflammatory myopathies. Neurology
59: 1170-1182
[Abstract][Full Text]
Tsao, C.-Y., Mendell, J. R., Kissel, J. T.
(2002). Dermatomyositis in Two Siblings and a Brief Review of Familial Dermatomyositis. J Child Neurol
17: 540-542
[Abstract]
De Bleecker, J. L., De Paepe, B., Vanwalleghem, I. E., Schroder, J. M.
(2002). Differential expression of chemokines in inflammatory myopathies. Neurology
58: 1779-1785
[Abstract][Full Text]
Pyne, D., Ehrenstein, M., Morris, V.
(2002). The therapeutic uses of intravenous immunoglobulins in autoimmune rheumatic diseases. Rheumatology (Oxford)
41: 367-374
[Full Text]
Benveniste, O., Cherin, P., Maisonobe, T., Merat, R., Chosidow, O., Mouthon, L., Guillevin, L., Flahault, A., Burland, M.-C., Klatzmann, D., Herson, S., Boyer, O.
(2001). Severe Perturbations of the Blood T Cell Repertoire in Polymyositis, But Not Dermatomyositis Patients. J. Immunol.
167: 3521-3529
[Abstract][Full Text]
DALAKAS, M C
(2001). Progress in inflammatory myopathies: good but not good enough. J. Neurol. Neurosurg. Psychiatry
70: 569-573
[Full Text]
Kelkar, P., Masood, M., Parry, G. J.
(2000). Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology
55: 83-88
[Abstract][Full Text]
Kono, H., Inokuma, S., Nakayama, H., Suzuki, M.
(2000). Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis
59: 372-376
[Abstract][Full Text]
Mozaffar, T., Pestronk, A.
(2000). Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J. Neurol. Neurosurg. Psychiatry
68: 472-478
[Abstract][Full Text]
Hindmarsh, E. J., Marks, R. M.
(1998). Complement Activation Occurs on Subendothelial Extracellular Matrix In Vitro and Is Initiated by Retraction or Removal of Overlying Endothelial Cells. J. Immunol.
160: 6128-6136
[Abstract][Full Text]
Topaloglu, H., Muntoni, F., Dubowitz, V., Sewry, C.
(1997). Expression of HLA Class I Antigens in Skeletal Muscle Is a Diagnostic Marker in Juvenile Dermatomyositis. J Child Neurol
12: 60-63
[Abstract]
Mancias, P., Bohan, T. P., Butler, I. J., Bhattacharjee, M. B.
(1994). Treatment-Resistant Eosinophilic Polymyositis in a Child. J Child Neurol
9: 446-448
Dalakas, M. C., Illa, I., Dambrosia, J. M., Soueidan, S. A., Stein, D. P., Otero, C., Dinsmore, S. T., McCrosky, S.
(1993). A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis. NEJM
329: 1993-2000
[Abstract][Full Text]
